LD/CD Infusion Improves "ON" Time, Outcomes in Parkinson's
Offering levodopa/carbidopa as a 24-hour continuous subcutaneous infusion could help to improve treatment on times and motor experiences of daily living compared with oral preparations.
Medscape Medical News
source https://www.medscape.com/viewarticle/996240?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/996240?src=rss
Comments
Post a Comment